Taha, Asmera M.
HRN: 22-12-89 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2022
CO-AMOXICLAV 625MG (TAB)
11/03/2022
11/09/2022
PO
1 Tab
BID
UTI
Waiting Final Action